Isoniazid 100 mg suppositories are a compounded dosage form designed to provide an alternative route of administration for isoniazid, particularly beneficial for patients who are unable to take oral medications. This formulation allows the medication to be absorbed systemically when inserted into the rectum or vagina, bypassing the gastrointestinal tract.

Isoniazid is a first-line antitubercular agent used in the treatment and prevention of tuberculosis (TB). It works by inhibiting the synthesis of mycolic acids in the bacterial cell wall, effectively killing the Mycobacterium tuberculosis organism. The suppository form ensures that patients continue to receive their necessary medication even when facing challenges such as vomiting, difficulty swallowing, or malabsorption issues.

For patients undergoing TB treatment, maintaining consistent drug levels is crucial to prevent the development of drug-resistant strains. The isoniazid suppository provides a reliable alternative for systemic drug delivery, ensuring therapeutic concentrations are achieved and maintained. This can be particularly important in pediatric patients, elderly patients, or those with compliance issues related to oral medications.

Prescribers may consider isoniazid suppositories for patients who exhibit intolerance to oral formulations or have co-existing conditions that preclude oral intake. This dosage form can enhance patient compliance, reduce gastrointestinal side effects, and facilitate uninterrupted therapy in intensive treatment phases.

Patients using isoniazid suppositories should carefully follow the administration instructions provided by their healthcare provider. The suppository should be gently inserted into the rectum or vagina, as directed, where it will dissolve and allow the medication to be absorbed into the bloodstream. Hands should be washed thoroughly before and after administration, and suppositories should be stored in a cool, dry place to maintain their effectiveness.

Potential side effects of isoniazid include liver toxicity, peripheral neuropathy, and hypersensitivity reactions. Patients should be monitored for symptoms such as fatigue, weakness, loss of appetite, nausea, vomiting, dark urine, or jaundice, and report these to their healthcare provider promptly. The concurrent use of pyridoxine (vitamin B6) is often recommended to mitigate the risk of peripheral neuropathy.

Drug interactions are an important consideration with isoniazid therapy. It can interact with medications such as phenytoin, carbamazepine, and certain anticoagulants, potentially leading to increased serum levels and toxicity. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid adverse interactions.

At Bayview Pharmacy, our team of compounding pharmacists is

Isoniazid 100 mg suppositories are a solid dosage form designed for insertion into a body cavity, typically the rectum or vagina, where they dissolve or melt to release medication for local or systemic absorption. This formulation is primarily used in the treatment of tuberculosis and other mycobacterial infections. It is crucial for both patients and prescribers to be aware of potential drug interactions when using isoniazid in this form to ensure safety and efficacy.

Isoniazid is known to interact with a variety of medications, which can either increase the risk of side effects or reduce the effectiveness of the treatment. One of the most significant interactions is with alcohol, which can increase the risk of liver damage. Patients are advised to avoid alcohol consumption while using isoniazid suppositories. Additionally, isoniazid can interact with certain anticonvulsants such as phenytoin and carbamazepine, potentially leading to increased plasma levels of these drugs and a higher risk of toxicity. Monitoring of drug levels and adjustment of dosages may be necessary.

Another important interaction is with rifampin, a common companion drug in tuberculosis treatment regimens. When used together, isoniazid and rifampin can increase the risk of hepatotoxicity. Regular liver function tests are recommended to monitor for any signs of liver damage. Isoniazid can also inhibit the metabolism of certain benzodiazepines, such as diazepam, leading to increased sedation and respiratory depression. Caution is advised when these medications are used concurrently.

Furthermore, isoniazid may interact with certain antacids containing aluminum salts, which can reduce the absorption of isoniazid. It is recommended to administer isoniazid at least one hour before or two hours after taking such antacids. Additionally, isoniazid can affect the metabolism of warfarin, a commonly used anticoagulant, potentially altering its anticoagulant effect. Close monitoring of INR levels and possible dose adjustments of warfarin may be required.

Patients should also be aware that isoniazid can interact with certain foods, particularly those high in tyramine and histamine, such as aged cheeses and cured meats, which can lead to adverse reactions like headaches, palpitations, and flushing. It is advisable to limit the intake of such foods during treatment.

For prescribers, it is essential to review the patient's current medication list for potential interactions before initiating isoniazid suppository therapy. Regular monitoring and patient education on recognizing signs of adverse interactions are key components of safe and effective treatment. If you have any questions or need further information, please reach out to us at Bayview Pharmacy.

Isoniazid 100 mg suppositories are a specialized formulation designed to deliver the active medication, isoniazid, directly into the body through insertion into a body cavity, typically the rectum. This solid dosage form is particularly beneficial for patients who may have difficulty swallowing oral medications or for those who require an alternative route of administration due to gastrointestinal issues. Upon insertion, the suppository dissolves or melts at body temperature, allowing the isoniazid to be absorbed through the mucous membranes of the rectal cavity. This method of administration facilitates both local and systemic absorption, ensuring that the medication reaches the bloodstream efficiently to exert its therapeutic effects.

Isoniazid is a first-line antitubercular agent used primarily in the treatment and prevention of tuberculosis (TB). It works by inhibiting the synthesis of mycolic acids, which are essential components of the mycobacterial cell wall. By disrupting the production of these acids, isoniazid effectively kills or inhibits the growth of Mycobacterium tuberculosis, the bacterium responsible for TB. The use of suppositories can be particularly advantageous in cases where oral administration is not feasible, such as in patients with severe nausea, vomiting, or malabsorption syndromes, or in pediatric or geriatric populations who may have difficulty with oral tablets.

For prescribers, it is important to consider the pharmacokinetics of isoniazid when administered via suppository. While the rectal route can provide a viable alternative to oral administration, factors such as the rate of dissolution, the presence of fecal matter, and individual patient variability can influence the absorption and bioavailability of the drug. Therefore, monitoring therapeutic levels and adjusting dosages as necessary is crucial to ensure optimal treatment outcomes. Additionally, patient education on the proper insertion technique and storage of suppositories is essential to maximize efficacy and minimize potential side effects.

Patients using isoniazid suppositories should be aware of potential side effects, which may include local irritation at the site of insertion, as well as systemic effects such as liver toxicity, peripheral neuropathy, and hypersensitivity reactions. Regular follow-up with healthcare providers is recommended to monitor for these adverse effects and to assess the effectiveness of the treatment regimen. As with any medication, adherence to the prescribed dosing schedule is critical to achieving the desired therapeutic outcomes.

If you have any questions or require further information about isoniazid 100 mg suppositories, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation or its use in treating tuberculosis.

Isoniazid 100 mg suppositories are primarily used for the treatment of tuberculosis, particularly in patients who are unable to take oral medications due to gastrointestinal issues or other contraindications. However, this formulation may have other potential uses that could benefit both patients and prescribers. One such use is in the management of latent tuberculosis infection (LTBI) in individuals who are at high risk of developing active tuberculosis but cannot tolerate oral isoniazid due to gastrointestinal side effects or swallowing difficulties. The rectal or vaginal administration of isoniazid via suppositories can provide an alternative route for systemic absorption, ensuring that patients receive the necessary prophylactic treatment without compromising their comfort or adherence to the medication regimen.

Additionally, isoniazid suppositories may be considered for use in patients with multi-drug resistant tuberculosis (MDR-TB) as part of a combination therapy regimen. In such cases, the suppository form can be particularly beneficial for patients who experience severe nausea or vomiting as a side effect of the intensive drug regimen required for MDR-TB treatment. By providing an alternative route of administration, suppositories can help maintain therapeutic drug levels and improve patient outcomes.

Furthermore, isoniazid suppositories might be explored for their potential use in treating certain non-tuberculous mycobacterial infections, especially in patients who have difficulty with oral administration. While this is not a standard use, ongoing research and clinical trials may provide more insights into the efficacy and safety of isoniazid in this context. It is important for prescribers to consider the individual needs and circumstances of each patient when determining the appropriateness of using isoniazid suppositories for off-label purposes.

For patients and healthcare providers interested in exploring these alternative uses of isoniazid suppositories, it is crucial to have a thorough discussion about the potential benefits and risks, as well as any monitoring requirements. As always, if you have any questions or need further information, please reach out to us at Bayview Pharmacy. We are here to support you in making informed decisions about your health and treatment options.